BioMérieux's market value is the price at which a share of BioMérieux trades on a public exchange. It measures the collective expectations of bioMrieux SA investors about its performance. BioMérieux is trading at 129.25 as of the 1st of January 2026. This is a 0.0077% down since the beginning of the trading day. The stock's lowest day price was 129.25. With this module, you can estimate the performance of a buy and hold strategy of bioMrieux SA and determine expected loss or profit from investing in BioMérieux over a given investment horizon. Check out BioMérieux Correlation, BioMérieux Volatility and BioMérieux Alpha and Beta module to complement your research on BioMérieux.
Please note, there is a significant difference between BioMérieux's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioMérieux is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioMérieux's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
BioMérieux 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioMérieux's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioMérieux.
0.00
12/02/2025
No Change 0.00
0.0
In 30 days
01/01/2026
0.00
If you would invest 0.00 in BioMérieux on December 2, 2025 and sell it all today you would earn a total of 0.00 from holding bioMrieux SA or generate 0.0% return on investment in BioMérieux over 30 days. BioMérieux is related to or competes with Mainz Biomed, Neuronetics, Prenetics Global, Fonar, IQVIA Holdings, Mettler Toledo, and Twist Bioscience. bioMrieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Ameri... More
BioMérieux Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioMérieux's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess bioMrieux SA upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioMérieux's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioMérieux's standard deviation. In reality, there are many statistical measures that can use BioMérieux historical prices to predict the future BioMérieux's volatility.
bioMrieux SA secures Sharpe Ratio (or Efficiency) of -0.0435, which signifies that the company had a -0.0435 % return per unit of risk over the last 3 months. bioMrieux SA exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioMérieux's Standard Deviation of 1.35, coefficient of variation of (2,373), and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.48, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, BioMérieux's returns are expected to increase less than the market. However, during the bear market, the loss of holding BioMérieux is expected to be smaller as well. At this point, bioMrieux SA has a negative expected return of -0.0606%. Please make sure to confirm BioMérieux's maximum drawdown, as well as the relationship between the daily balance of power and price action indicator , to decide if bioMrieux SA performance from the past will be repeated at some point in the near future.
Auto-correlation
0.79
Good predictability
bioMrieux SA has good predictability. Overlapping area represents the amount of predictability between BioMérieux time series from 2nd of December 2025 to 17th of December 2025 and 17th of December 2025 to 1st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of bioMrieux SA price movement. The serial correlation of 0.79 indicates that around 79.0% of current BioMérieux price fluctuation can be explain by its past prices.
Correlation Coefficient
0.79
Spearman Rank Test
0.95
Residual Average
0.0
Price Variance
3.73
bioMrieux SA lagged returns against current returns
Autocorrelation, which is BioMérieux pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BioMérieux's pink sheet expected returns. We can calculate the autocorrelation of BioMérieux returns to help us make a trade decision. For example, suppose you find that BioMérieux has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
BioMérieux regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BioMérieux pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BioMérieux pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BioMérieux pink sheet over time.
Current vs Lagged Prices
Timeline
BioMérieux Lagged Returns
When evaluating BioMérieux's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BioMérieux pink sheet have on its future price. BioMérieux autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BioMérieux autocorrelation shows the relationship between BioMérieux pink sheet current value and its past values and can show if there is a momentum factor associated with investing in bioMrieux SA.
Other Information on Investing in BioMérieux Pink Sheet
BioMérieux financial ratios help investors to determine whether BioMérieux Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioMérieux with respect to the benefits of owning BioMérieux security.